Latest News about GLPG
Recent news which mentions GLPG
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 7, 2022
November 07, 2022
From Benzinga
After FDA, European Agency Limits Use Of Certain JAK Inhibitors Amid Safety Concerns
October 31, 2022
From Benzinga
3 Biotech Stocks to Sell in October
September 29, 2022
From InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For September 9, 2022
September 09, 2022
From Benzinga
Lyft, DoorDash, Expedia And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
August 05, 2022
From Benzinga
From Benzinga
From Benzinga
From Benzinga
From Benzinga
The Daily Biotech Pulse: J&J Unit Announces Research Collaboration With Remix, Regencell Touts COVID Data, Decision Day For Agios
February 17, 2022
From Benzinga
The Week Ahead In Biotech (Feb. 13-19): Agios FDA Meeting, Avenue Adcom, Earnings And More
February 13, 2022
From Benzinga
The Daily Biotech Pulse: Sanofi, Bristol-Myers Squibb Gain On Earnings, Valneva-Pfizer Tout Positive Lyme Disease Vaccine Data, UNITY Biotech Restructures
February 04, 2022
From Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
January 31, 2022
From Benzinga
Mid-Afternoon Market Update: US Stocks Turns Lower In Volatile Trading; Nasdaq Tumbles 150 Points
January 27, 2022
From Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
January 27, 2022
From Benzinga
Mid-Day Market Update: Dow Jumps Over 500 Points; Seagate Shares Surge On Upbeat Results
January 27, 2022
From Benzinga
46 Stocks Moving In Thursday's Mid-Day Session
January 27, 2022
From Benzinga
Mid-Morning Market Update: US Markets Open Higher As GDP Rises 6.9% In Fourth Quarter
January 27, 2022
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 27, 2022
January 27, 2022
From Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
January 27, 2022
From Benzinga
The Daily Biotech Pulse: Galapagos Appoints J&J Exec As CEO, Aridis Gets Funding For Antiviral Treatment, Moderna Starts Omicron-Specific Booster Study
January 27, 2022
From Benzinga
From InvestorPlace
26 Stocks Moving in Thursday's Pre-Market Session
January 27, 2022
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
More ways to get to us
Facebook
Twitter
YouTubeContact the Lethbridge Herald
504 - 7th Street South
Lethbridge, AB T1J 3Z7
[P] (403) 328-4411
[F] (403)328-4536
Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433
© 1996-2017 The Lethbridge Herald, A Division of Continental Newspapers Canada Ltd.